Lv1
20 积分 2025-03-20 加入
Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies
12天前
已完结
Mechanisms of resistance to CAR T cell therapy
12天前
已完结
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
14天前
已完结
CTLA-4 tail fusion enhances CAR-T antitumor immunity
14天前
已完结
Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
26天前
已完结
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
30天前
已完结
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
1个月前
已完结
Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma
4个月前
已完结
Preclinical development and a phase 1 trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
4个月前
已完结
T Cell Receptor Engineered Lymphocytes for Cancer Therapy
5个月前
已完结
皖公网安备34019202002308
